Mitra Keluarga Karyasehat Tbk PT (MIKA) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Mitra Keluarga Karyasehat Tbk PT stock IDR 1,696, price IDR 1,300, upside +30.4%, quality 71 out of 100. Rating: undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 4, 2026.
How to read this chart
60‑month range 1,280 IDR – 3,128 IDR · fair‑value band 1,065 IDR – 2,260 IDR · the 1,300 IDR price screens below the 1,696 IDR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 4, 2026.
Follow Mitra Keluarga Karyasehat Tbk PT in your weekly email
Every Wednesday you see whether Mitra Keluarga Karyasehat Tbk PT is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
PT Mitra Keluarga Karyasehat Tbk, together with its subsidiaries, owns and operates hospitals in Indonesia. The company also offers healthcare platform services.
Show moreShow less
Its hospital network comprises Mitra Keluarga Hospitals and Kasih Group Hospitals located in Greater Jakarta, West Java, East Java, and Central Java. The company was founded in 1989 and is headquartered in Jakarta, Indonesia.
PT Mitra Keluarga Karyasehat Tbk is a subsidiary of PT Griyainsani Cakrasadaya.
Stock analysis
Mitra Keluarga Karyasehat Tbk PT (MIKA) currently trades at 1,300 IDR, while our model-based Fair Value estimate is 1,696 IDR, implying the stock looks roughly 23% undervalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of 2,181 IDR per share, and 14 of the 26 models we run sit above the 1,300 IDR price.
Bear case: the Dividend Discount group reads lowest at 517.62 IDR, and 12 of the 26 models stay below the price. Data coverage for this calculation is low.
Scenario range: 1,065 IDR (bear) to 2,260 IDR (bull), the price of 1,300 IDR sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 71/100 (solid quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Mitra Keluarga Karyasehat Tbk PT reported revenue of 5.4T IDR in FY2025 versus 4.4T IDR in FY2021, a compound +5.4%/yr. Reported net income was 1.4T IDR in FY2025, compounding +2.7%/yr from FY2021.
Key figures
Market cap 18.1T IDR (≈ $999M) Small · P/E ratio 12.5 · P/S ratio 3.20 · EPS (TTM) 104.31 IDR · Dividend yield 3.3% · Net margin 25.3% · Return on equity 18.4% · Return on assets (EBIT) 19.3% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 84 out of 100 (low confidence).
What moves the price
The share trades about 49% below its 52-week high and 2% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −1% fair-value upside, at 30%, MIKA screens cheaper than that median.
Fair Value models
Bear1,065 IDRFair Value 1,696 IDRBull2,260 IDR
Price 1,300 IDR · Upside +30.4%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (52.41 IDR per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+10.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.4%
Start year 2020 (pandemic). Over 10 years: +9.6% a year
Revenue growth 13 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.4%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in IDR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis. Measured in IDR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+12.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year+8.7%
Dividend (yield on the price)3.3%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.10.7% vs 9.6%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.33% → 31%
Pace: the 5-year rate starts in 2020 (pandemic)
Growth Forecast
Price in line with expectations
The price assumes about as much growth as the company has delivered so far and about what analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+10.5%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+9.4%
Yearly sales growth analysts expect, extended to five years.
After inflation (Indonesia: IMF forecast 2.6% a year to 2030, 2.9% from 2016 to 2025) that is about +7.7% a year for the price and +6.6% for the forecasts.
Compare Mitra Keluarga Karyasehat Tbk PT with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 233 stocks
Beats the industry median on 11/15 measures
Overall it ranks above its industry peers.
Valuation
Quality Score71 · Top 25%
Fair Value upside+30.4% · Above median
Profitability
Return on equity (12 months)18.4% · Top 25%
Return on assets14.7% · Top 25%
Net margin (12 months)25.3% · Top 25%
Operating margin (12 months)33.6% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)5.7% · Below median
Dividend yield (12 months)3.3% · Above median
Balance sheet
Debt / equity0.00× · Lowest 25%
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
P/E (12 months)12.5× · Cheapest 25%
P/B2.49× · Pricier than median
P/S (12 months)3.20× · Priciest 25%
Price / free cash flow (fiscal year)18.9× · Pricier than median
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Mitra Keluarga Karyasehat Tbk PT Fair Value". https://www.fairvalue-calculator.com/stock/MIKA
Frequently asked questions
Is Mitra Keluarga Karyasehat Tbk PT (MIKA) overvalued or undervalued?
As of Nov 4, 2026, our model estimates a fair value of 1,696 IDR versus a price of 1,300 IDR, about +30% upside (undervalued).
What is the fair value of MIKA?
Our model-based fair value for Mitra Keluarga Karyasehat Tbk PT is 1,696 IDR (as of Nov 4, 2026), built from audited fundamentals. The current price: 1,300 IDR.
What is the quality score of MIKA?
Mitra Keluarga Karyasehat Tbk PT has a Quality Score of 71/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Mitra Keluarga Karyasehat Tbk PT (MIKA)?
Our model-based price target is the fair value of 1,696 IDR (as of Nov 4, 2026) from 26 valuation models. Cautious scenario 1,065 IDR, optimistic scenario 2,260 IDR. It is a calculation from audited fundamentals, not an analyst target.
What is the Mitra Keluarga Karyasehat Tbk PT stock forecast for 2026?
Our models put fair value at 1,696 IDR, about +30% upside versus a price of 1,300 IDR (undervalued). Cautious scenario 1,065 IDR, optimistic scenario 2,260 IDR. The calculation is refreshed regularly with new filings.
What is the revenue of Mitra Keluarga Karyasehat Tbk PT (MIKA)?
Mitra Keluarga Karyasehat Tbk PT reported trailing-twelve-month revenue of about 5.7T IDR (latest available figure, as of Nov 4, 2026).
Does Mitra Keluarga Karyasehat Tbk PT pay a dividend?
Mitra Keluarga Karyasehat Tbk PT currently shows a dividend yield of 3.31% relative to its recent price (as of Nov 4, 2026).
How much is the dividend of Mitra Keluarga Karyasehat Tbk PT (MIKA) and when is the ex-dividend date?
Mitra Keluarga Karyasehat Tbk PT pays a dividend of 43.00 IDR per share a year, a dividend yield of 3.3%. The last ex-dividend date was Jun 19, 2026. A dividend has been paid every year since 2019. The payout ratio is 41.2% of earnings. Free cash flow covers the dividend 1.61 times. Our assessment: Well covered. A low payout and the dividend is fully funded by free cash flow, a comfortable, sustainable dividend.
What growth is priced into Mitra Keluarga Karyasehat Tbk PT (MIKA)?
For today's price to be fair in a discounted-cash-flow model, Mitra Keluarga Karyasehat Tbk PT would have to grow free cash flow by +10.5 % per year for five years (discount rate 12.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +9.4 % per year. As of Nov 4, 2026.
What discount rate (WACC) does the fair value of MIKA use?
Our models discount Mitra Keluarga Karyasehat Tbk PT at 12.0 %: a base by market capitalisation (small), damped by beta 0.04, country premium for Indonesia. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Mitra Keluarga Karyasehat Tbk PT that is +10.5 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (12.0 %) and the same formula as our fair value.
How much growth has Mitra Keluarga Karyasehat Tbk PT (MIKA) delivered so far?
Over the past 5 years revenue at Mitra Keluarga Karyasehat Tbk PT grew +9.4 % a year. The price currently implies free-cash-flow growth of +10.5 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Mitra Keluarga Karyasehat Tbk PT (MIKA) growing?
The median revenue growth in the sector is +6.2 % a year. That is the yardstick for the growth priced into Mitra Keluarga Karyasehat Tbk PT (+10.5 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Mitra Keluarga Karyasehat Tbk PT (MIKA)?
The free-cash-flow yield on the price is 5.30 %: that much free cash flow Mitra Keluarga Karyasehat Tbk PT produces per unit of market value. When it exceeds the discount rate of our models (12.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Mitra Keluarga Karyasehat Tbk PT (MIKA)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Mitra Keluarga Karyasehat Tbk PT it is 1,696 IDR per share (as of Nov 4, 2026), against a price of 1,300 IDR. It is the blended result of 26 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Mitra Keluarga Karyasehat Tbk PT stock overvalued or undervalued in 2026?
As of Nov 4, 2026, MIKA trades below its calculated fair value: price 1,300 IDR, fair value 1,696 IDR, a gap of about +30% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of MIKA?
No. The price is what the market pays today (1,300 IDR); the fair value is what the company's own numbers justify (1,696 IDR). For Mitra Keluarga Karyasehat Tbk PT the two are 395.80 IDR per share apart. That gap is exactly why we show both numbers side by side.
How much is Mitra Keluarga Karyasehat Tbk PT worth?
The market values Mitra Keluarga Karyasehat Tbk PT at about 18.1T IDR (market capitalisation, as of Nov 4, 2026). Per share that is 1,300 IDR; our models calculate a fair value of 1,696 IDR per share.
What do the bullish and bearish scenarios say about MIKA?
Our models span a range for Mitra Keluarga Karyasehat Tbk PT: cautious scenario 1,065 IDR, base 1,696 IDR, optimistic 2,260 IDR per share (as of Nov 4, 2026, price 1,300 IDR). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of MIKA?
Mitra Keluarga Karyasehat Tbk PT trades at a price-to-earnings ratio of 12.5 (as of Nov 4, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 1,696 IDR is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2016 to 2025), reported earnings, FY2025 ex one-offs: 41.3. Other multiples: PEG 1.0, P/B 2.5, P/S 3.2, EV/EBITDA 6.8.
What is the PEG ratio of MIKA?
The PEG ratio of Mitra Keluarga Karyasehat Tbk PT is 0.97 (P/E divided by earnings growth, as of Nov 4, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of Mitra Keluarga Karyasehat Tbk PT (MIKA)?
Balance-sheet figures for Mitra Keluarga Karyasehat Tbk PT (as of Nov 4, 2026): return on equity 18.4%, debt of 0.00 per unit of equity. They feed the Quality Score of 71/100, which measures business quality independently of the share price.
How far is MIKA from its 52-week high?
Mitra Keluarga Karyasehat Tbk PT trades at 1,300 IDR, about 49% below its 52-week high of 2,568 IDR and 2% above the low of 1,280 IDR (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 1,696 IDR is for.
Which stocks are comparable to Mitra Keluarga Karyasehat Tbk PT?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Tenet Healthcare Corporation, Dr. Sulaiman Al Habib Medical Services Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Mitra Keluarga Karyasehat Tbk PT stock attractive at the current price?
The data as of Nov 4, 2026: price 1,300 IDR, calculated fair value 1,696 IDR (+30%), Quality Score 71/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of MIKA calculated?
We run Mitra Keluarga Karyasehat Tbk PT through 26 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 1,696 IDR builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. Mitra Keluarga Karyasehat Tbk PT currently trades 23% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Mitra Keluarga Karyasehat Tbk PT (MIKA)?
The closing price on Nov 6, 2026 was 1,300 IDR. Our model-based fair value is 1,696 IDR, about +30% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Mitra Keluarga Karyasehat Tbk PT right now?
The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (71/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (1,065 IDR to 2,260 IDR) leaves room in how you read the outcome.
Where does the earnings growth of Mitra Keluarga Karyasehat Tbk PT (MIKA) come from?
Earnings per share at Mitra Keluarga Karyasehat Tbk PT grew +7.8 % a year from 2014 to 2025. Broken into its drivers: revenue per share +9.6 %, EBIT margin +0.2 %, tax rate −0.3 %, residual (interest, one-offs) −1.4 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Mitra Keluarga Karyasehat Tbk PT
How large is the market capitalisation of Mitra Keluarga Karyasehat Tbk PT (MIKA)?
The market capitalisation of Mitra Keluarga Karyasehat Tbk PT is 18.1T IDR (≈ $999M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Mitra Keluarga Karyasehat Tbk PT (MIKA)?
The price-to-sales ratio of Mitra Keluarga Karyasehat Tbk PT is 3.20 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Mitra Keluarga Karyasehat Tbk PT (MIKA)?
Earnings per share at Mitra Keluarga Karyasehat Tbk PT are 104.31 IDR (price ÷ EPS = P/E 12.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Mitra Keluarga Karyasehat Tbk PT (MIKA)?
The dividend yield of Mitra Keluarga Karyasehat Tbk PT is 3.3% (payout 41.2%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Mitra Keluarga Karyasehat Tbk PT (MIKA)?
The net margin of Mitra Keluarga Karyasehat Tbk PT is 25.3% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Mitra Keluarga Karyasehat Tbk PT (MIKA)?
The return on equity (ROE) of Mitra Keluarga Karyasehat Tbk PT is 18.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Mitra Keluarga Karyasehat Tbk PT (MIKA)?
On an EBIT basis the return on assets of Mitra Keluarga Karyasehat Tbk PT is 19.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Mitra Keluarga Karyasehat Tbk PT (MIKA)?
The operating margin of Mitra Keluarga Karyasehat Tbk PT is 33.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Mitra Keluarga Karyasehat Tbk PT (MIKA)?
Revenue at Mitra Keluarga Karyasehat Tbk PT is growing +5.7% versus a year earlier (3y avg +9.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Mitra Keluarga Karyasehat Tbk PT (MIKA)?
Earnings per share at Mitra Keluarga Karyasehat Tbk PT are growing +6.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Mitra Keluarga Karyasehat Tbk PT (MIKA) hold?
Mitra Keluarga Karyasehat Tbk PT holds more cash than debt, 2.5T IDR net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Mitra Keluarga Karyasehat Tbk PT in the live analysis
One click puts Mitra Keluarga Karyasehat Tbk PT on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 4, 2026